Estrella Immunopharma Inc — Cash Flow (NASDAQ:ESLA)

Financials

Cash from operating activities -316.16 K-1.04 M-16.07 M -3.83 M Cash from investing activities -45.19 M36.17 M4.96 M — Cash from financing activities 45.98 M-35.56 M12.79 M 2.17 M Free cash flow -316.16 K-1.04 M-16.07 M -3.83 M

新闻

Estrella在淋巴瘤试验中报告100%完全缓解率

Estrella reports 100% complete response rate in lymphoma trial

Estrella将在ASTCT会议上展示CD19靶向细胞疗法的一期数据

Estrella to present phase 1 data on CD19-targeted cell therapy

Estrella Immunopharma收到纳斯达克关于延迟年度股东大会的通知

Estrella Immunopharma receives Nasdaq notice for delayed annual meeting

Estrella Immunopharma完成800万美元注册直接发行

Estrella Immunopharma closes $8 million registered direct offering

Estrella Immunopharma股价在宣布800万美元融资后下跌

Estrella Immunopharma stock falls after announcing $8 million offering

Estrella Immunopharma通过注册发行筹集800万美元资金

Estrella Immunopharma raises $8 million through registered offering